Exit of OrganOx within NextGen’s portfolio

🚀 Big news for La Maison NextGen !

We are delighted to announce a new exit within the portfolio of our fund La Maison NextGen.

Organox, a global pioneer in organ preservation and transportation, is entering a new growth phase through its acquisition by Terumo, a publicly listed Japanese leader and international medtech player.

👏 Congratulations to the OrganOx team for their vision and commitment, and to our partner LAUXERA CAPITAL PARTNERS for their valuable support.

Beyond financial success, this transaction perfectly reflects the mission of La Maison Partners :
✨ Supporting high-potential technology champions,
✨ Building a dynamic and resilient portfolio,
✨ Creating long-term value for our investors,
✨ Identifying and co-investing alongside the best teams.